Trial Profile
Effect of Saxagliptin on Body Fat , Glucose and Beta Cell Function in Patients With Newly Diagnosed Pre-Diabetes Mellitus and Obesity
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 Jan 2018
Price :
$35
*
At a glance
- Drugs Saxagliptin (Primary) ; Metformin
- Indications Obesity; Prediabetic state; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 24 Sep 2014 Planned primary completion date changed from 1 Feb 2014 to 1 Dec 2014 as reported by ClinicalTrials.gov record.
- 18 Oct 2013 New trial record